Neuroserpin (NS) inactivation of tissue plasminogen activator (tPA) in brain reduces neurotoxicity. However several familial point mutations in its gene are linked with a neurodegenerative disease termed Familial Encephalopathy with Neuroserpin Inclusion Bodies (FENIB) that results in epilepsy/dementia. Variable expression level of the NS has been linked to several other neurological pathologies like Alzheimer's, glaucoma and ischemic stroke. A familial variant of NS that leads to mortality, Ser52Arg (S52R) was made using site directed mutagenesis. A circular dichroism study indicated close correspondence in the secondary structures of S52R and the recombinant NS. However, fluorometric analysis showed a conformational deformation and a shift towards more hydrophobic environment. Consequently, S52R showed an enhanced ability to form polymers based on the native PAGE and Thioflavin T binding studies. Epigallocatechin gallate (EGCG), a polyphenol with neuroprotective properties, is shown to have a high affinity for both, the NS and the S52R in a comprehensive screening of the natural compounds. Interestingly, S52R showed reduction in the polymer formation and significant retention of its tPA inhibition activity on incubation with ECGC (100 μM). A site specific labelling of S52 using Alexa fluor 488C5 maleimide dye indicated that this region undergoes burial on addition of the tPA. A guanidium hydrochloride based denaturation study showed that EGCG increases the conformational stability of a folding intermediate. EGCG binds to the native NS, a folding intermediate and the natural variant of NS and retards the polymer formation with significant retention of tPA inhibition activity with implications in reducing the pathological symptoms.

